Calcium Channel Blocker Market 2028 By Drug Class, Distribution Channel, and Geography | The Insight Partners

Calcium Channel Blocker Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Dihydropyridine, Benzothizepine, Phenylalkylamine); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others); and Geography

Report Code: TIPRE00020510 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Calcium channel blockers are prescribing drugs, used for the treatment of high blood pressure. The blockers slow down the movement of calcium which is flowing through the heart and blood vessels. This slowing of calcium in blood vessels allows regular flow of blood, that helps to lower the blood pressure. The calcium channel blockers are prominently used for certain heart conditions such as Coronary artery disease, chest pain, and irregular heartbeats.

MARKET DYNAMICS

Increasing prevalence of heart diseases is one of the prominent factors contributing to the growth of the calcium channel blocker market. Moreover, gradual shift in lifestyle of people is also anticipated to offer lucrative opportunity for the market growth. However, increased risk of adverse effects caused due to the drugs is expected to hamper the market growth.

MARKET SCOPE

The "Calcium Channel Blocker Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Calcium Channel Blocker Market with detailed market segmentation by drug class and distribution channel. The Calcium Channel Blocker Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Calcium Channel Blocker Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Calcium Channel Blocker Market is segmented on the basis of drug class and distribution channel. On the basis of drug class, the market is segmented as dihydropyridine, benzothizepine, and phenylalkylamine. Based on distribution channel, the market segmented as hospital pharmacies, retail pharmacies, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Calcium Channel Blocker Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Calcium Channel Blocker Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Calcium Channel Blocker Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Calcium Channel Blocker Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Calcium Channel Blocker Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Calcium Channel Blocker Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Calcium Channel Blocker Market.

The report also includes the profiles of key players in Calcium Channel Blocker Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbvie Inc
  •   Alvogen
  •   Arbor Pharmaceuticals LLC
  •   Bausch Health Company Inc.
  •   Covis Pharma BV
  •   Exela Pharma Sciences, LLC
  •   Novartis AG
  •   Pfizer Inc
  •   Silvergate Pharmaceuticals Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Calcium Channel Blocker Market - By Drug Class
1.3.2 Calcium Channel Blocker Market - By Distribution Channel
1.3.3 Calcium Channel Blocker Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CALCIUM CHANNEL BLOCKER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CALCIUM CHANNEL BLOCKER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CALCIUM CHANNEL BLOCKER MARKET - GLOBAL MARKET ANALYSIS
6.1. CALCIUM CHANNEL BLOCKER - GLOBAL MARKET OVERVIEW
6.2. CALCIUM CHANNEL BLOCKER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CALCIUM CHANNEL BLOCKER MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. DIHYDROPYRIDINE
7.3.1. Overview
7.3.2. Dihydropyridine Market Forecast and Analysis
7.4. BENZOTHIZEPINE
7.4.1. Overview
7.4.2. Benzothizepine Market Forecast and Analysis
7.5. PHENYLALKYLAMINE
7.5.1. Overview
7.5.2. Phenylalkylamine Market Forecast and Analysis
8. CALCIUM CHANNEL BLOCKER MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CALCIUM CHANNEL BLOCKER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Calcium Channel Blocker Market Overview
9.1.2 North America Calcium Channel Blocker Market Forecasts and Analysis
9.1.3 North America Calcium Channel Blocker Market Forecasts and Analysis - By Drug Class
9.1.4 North America Calcium Channel Blocker Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Calcium Channel Blocker Market Forecasts and Analysis - By Countries
9.1.5.1 United States Calcium Channel Blocker Market
9.1.5.1.1 United States Calcium Channel Blocker Market by Drug Class
9.1.5.1.2 United States Calcium Channel Blocker Market by Distribution Channel
9.1.5.2 Canada Calcium Channel Blocker Market
9.1.5.2.1 Canada Calcium Channel Blocker Market by Drug Class
9.1.5.2.2 Canada Calcium Channel Blocker Market by Distribution Channel
9.1.5.3 Mexico Calcium Channel Blocker Market
9.1.5.3.1 Mexico Calcium Channel Blocker Market by Drug Class
9.1.5.3.2 Mexico Calcium Channel Blocker Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Calcium Channel Blocker Market Overview
9.2.2 Europe Calcium Channel Blocker Market Forecasts and Analysis
9.2.3 Europe Calcium Channel Blocker Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Calcium Channel Blocker Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Calcium Channel Blocker Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Calcium Channel Blocker Market
9.2.5.1.1 Germany Calcium Channel Blocker Market by Drug Class
9.2.5.1.2 Germany Calcium Channel Blocker Market by Distribution Channel
9.2.5.2 France Calcium Channel Blocker Market
9.2.5.2.1 France Calcium Channel Blocker Market by Drug Class
9.2.5.2.2 France Calcium Channel Blocker Market by Distribution Channel
9.2.5.3 Italy Calcium Channel Blocker Market
9.2.5.3.1 Italy Calcium Channel Blocker Market by Drug Class
9.2.5.3.2 Italy Calcium Channel Blocker Market by Distribution Channel
9.2.5.4 Spain Calcium Channel Blocker Market
9.2.5.4.1 Spain Calcium Channel Blocker Market by Drug Class
9.2.5.4.2 Spain Calcium Channel Blocker Market by Distribution Channel
9.2.5.5 United Kingdom Calcium Channel Blocker Market
9.2.5.5.1 United Kingdom Calcium Channel Blocker Market by Drug Class
9.2.5.5.2 United Kingdom Calcium Channel Blocker Market by Distribution Channel
9.2.5.6 Rest of Europe Calcium Channel Blocker Market
9.2.5.6.1 Rest of Europe Calcium Channel Blocker Market by Drug Class
9.2.5.6.2 Rest of Europe Calcium Channel Blocker Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Calcium Channel Blocker Market Overview
9.3.2 Asia-Pacific Calcium Channel Blocker Market Forecasts and Analysis
9.3.3 Asia-Pacific Calcium Channel Blocker Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Calcium Channel Blocker Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Calcium Channel Blocker Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Calcium Channel Blocker Market
9.3.5.1.1 Australia Calcium Channel Blocker Market by Drug Class
9.3.5.1.2 Australia Calcium Channel Blocker Market by Distribution Channel
9.3.5.2 China Calcium Channel Blocker Market
9.3.5.2.1 China Calcium Channel Blocker Market by Drug Class
9.3.5.2.2 China Calcium Channel Blocker Market by Distribution Channel
9.3.5.3 India Calcium Channel Blocker Market
9.3.5.3.1 India Calcium Channel Blocker Market by Drug Class
9.3.5.3.2 India Calcium Channel Blocker Market by Distribution Channel
9.3.5.4 Japan Calcium Channel Blocker Market
9.3.5.4.1 Japan Calcium Channel Blocker Market by Drug Class
9.3.5.4.2 Japan Calcium Channel Blocker Market by Distribution Channel
9.3.5.5 South Korea Calcium Channel Blocker Market
9.3.5.5.1 South Korea Calcium Channel Blocker Market by Drug Class
9.3.5.5.2 South Korea Calcium Channel Blocker Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Calcium Channel Blocker Market
9.3.5.6.1 Rest of Asia-Pacific Calcium Channel Blocker Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Calcium Channel Blocker Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Calcium Channel Blocker Market Overview
9.4.2 Middle East and Africa Calcium Channel Blocker Market Forecasts and Analysis
9.4.3 Middle East and Africa Calcium Channel Blocker Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Calcium Channel Blocker Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Calcium Channel Blocker Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Calcium Channel Blocker Market
9.4.5.1.1 South Africa Calcium Channel Blocker Market by Drug Class
9.4.5.1.2 South Africa Calcium Channel Blocker Market by Distribution Channel
9.4.5.2 Saudi Arabia Calcium Channel Blocker Market
9.4.5.2.1 Saudi Arabia Calcium Channel Blocker Market by Drug Class
9.4.5.2.2 Saudi Arabia Calcium Channel Blocker Market by Distribution Channel
9.4.5.3 U.A.E Calcium Channel Blocker Market
9.4.5.3.1 U.A.E Calcium Channel Blocker Market by Drug Class
9.4.5.3.2 U.A.E Calcium Channel Blocker Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Calcium Channel Blocker Market
9.4.5.4.1 Rest of Middle East and Africa Calcium Channel Blocker Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Calcium Channel Blocker Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Calcium Channel Blocker Market Overview
9.5.2 South and Central America Calcium Channel Blocker Market Forecasts and Analysis
9.5.3 South and Central America Calcium Channel Blocker Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Calcium Channel Blocker Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Calcium Channel Blocker Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Calcium Channel Blocker Market
9.5.5.1.1 Brazil Calcium Channel Blocker Market by Drug Class
9.5.5.1.2 Brazil Calcium Channel Blocker Market by Distribution Channel
9.5.5.2 Argentina Calcium Channel Blocker Market
9.5.5.2.1 Argentina Calcium Channel Blocker Market by Drug Class
9.5.5.2.2 Argentina Calcium Channel Blocker Market by Distribution Channel
9.5.5.3 Rest of South and Central America Calcium Channel Blocker Market
9.5.5.3.1 Rest of South and Central America Calcium Channel Blocker Market by Drug Class
9.5.5.3.2 Rest of South and Central America Calcium Channel Blocker Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CALCIUM CHANNEL BLOCKER MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CALCIUM CHANNEL BLOCKER MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALVOGEN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ARBOR PHARMACEUTICALS LLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAUSCH HEALTH COMPANY INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. COVIS PHARMA BV
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EXELA PHARMA SCIENCES, LLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SILVERGATE PHARMACEUTICALS INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbvie Inc
2. Alvogen
3. Arbor Pharmaceuticals LLC
4. Bausch Health Company Inc.
5. Covis Pharma BV
6. Exela Pharma Sciences, LLC
7. Novartis AG
8. Pfizer Inc
9. Silvergate Pharmaceuticals Inc
TIPRE00020510
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount